350 mg leronlimab Clinical Trials

1 actively recruiting trial across 1 location

Also known as: PRO 140

Filter by location:

Irvine, California1 trial

A Phase 2 Study of Leronlimab in Combination With TAS-102 + Bevacizumab in Previously Treated Participants With mCRC

City of Hope Orange County Lennar Foundation Cancer Center

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.